CMC Comparability Protocols Should Specify Tests, Analytical Procedures
This article was originally published in The Tan Sheet
Executive Summary
Companies should include a list of tests and studies they expect to conduct on drug products in their chemistry, manufacturing and controls comparability protocols, an FDA draft guidance suggests
You may also be interested in...
GMP Dispute Resolution Pilot Proposed To Evaluate Three-Stage Process
An FDA dispute resolution 12-month pilot will evaluate a proposed three-level process to resolve disagreements involving "technical and scientific" disputes that arise as a result of drug good manufacturing practice inspections
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands